🔎 Trials Near Me

Domov › Nadváha › Texas › San Antonio

Klinické štúdie Nadváha v meste San Antonio, TX

34 štúdií pre Nadváha hľadá účastníkov v zariadeniach v meste San Antonio a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
  • Kailera Clinical Site, San Antonio
Vek 18 až 85 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Prebieha náborFáza 3
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • Pinnacle Clinical Research, San Antonio
  • a 1 ďalších
Vek 8 až 18 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07253285

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Prebieha náborFáza 1
  • Endeavor Clinical Trials, San Antonio
Vek 18 až 65 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Prebieha náborFáza 3
  • Sleep Therapy Research Center, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Prebieha náborFáza 3
  • IMA Clinical Research San Antonio, San Antonio
  • VIP Trials, San Antonio, TX 78230
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Prebieha náborFáza 3
  • VIP Trials, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07595549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Prebieha náborFáza 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Prebieha náborFáza 3
  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Prebieha náborFáza 3
  • IMA Clinical Research San Antonio, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Prebieha náborFáza 3
  • IMA Clinical Research San Antonio, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Prebieha náborFáza 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Prebieha náborFáza 3
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Prebieha náborFáza 3
  • Bandera Family Health Care, San Antonio
  • Consano Clinical Research - Shavano Park, Shavano Park · 12 míľ odtiaľ
Vek 45 až 99 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Prebieha náborFáza 3
  • IMA Clinical Research San Antonio, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Prebieha náborFáza 3
  • VIP Trials, San Antonio
  • Endeavor Clinical Trials, San Antonio
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • Endeavor Clinical Trials, San Antonio
Vek 18 až 75 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Prebieha náborFáza 3
  • AURORA-1 Clinical Site, San Antonio
  • AURORA-1 Clinical Site, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Prebieha náborFáza 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Prebieha náborFáza 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Prebieha náborFáza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Prebieha náborFáza 3
  • Pinnacle Clinical Research - South San Antonio, San Antonio
  • IMA Clinical Research - San Antonio, San Antonio
  • Consano Clinical Research, Shavano Park · 12 míľ odtiaľ
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
  • ACCOMPLISH-2 Research Site, San Antonio
  • ACCOMPLISH-2 Research Site, San Antonio
Vek 18 až 79 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • Endeavor Clinical Trials, San Antonio
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prebieha náborFáza 2
  • Consano Clinical Research, LLC, Shavano Park · 12 míľ odtiaľ
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07215559

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
  • ICON, San Antonio
Vek 18 až 55 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07767175

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Prebieha náborFáza 3
  • Clinical Trials of Texas, San Antonio
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07684235

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
  • ICON Early Phase Services, LLC, San Antonio
Vek 18 až 65 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Prebieha náborFáza 3
  • Research Site, San Antonio
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07784725

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
  • ICON Early Phase Services, San Antonio
Vek 18 až 65 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07738614

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Prebieha náborFáza 3
  • ACCOMPLISH-1 Research Site, San Antonio
Vek 18 až 79 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT07654361

Štúdie Nadváha v iných mestách

Iné štúdie v San Antonio

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.